Interview with MILabs founder at World Physics News

Video report: MILabs founder Freek Beekman describes how high-resolution SPECT systems play an invaluable role in small-animal imaging, e.g. for development of new therapeutic strategies for human medicine, offering, for example, a means to accurately track (the response of) pharmaceuticals in animal models of cancer, diabetes and other diseases. Imaging tiny animals such as mice necessitates extremely high-resolution, artefact free imaging. In this exclusive video interview, Freek Beekman dicsusses recent achievements in improving SPECT resolution from the typical clinical value of 1 cm, to 0.35 mm in a living mouse.
  Link to full article